Cogent Biosciences, Inc.

Direct answer

Cogent Biosciences, Inc. is publicly traded on NASDAQ under the ticker COGT.

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced...

Can you invest in Cogent Biosciences, Inc.?

Yes. Cogent Biosciences, Inc. is publicly traded on NASDAQ under the ticker COGT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cogent Biosciences, Inc.

Detailed equity research is provided by MarketSnap.